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Abstract 
 New triazole antifungals voriconazole, itraconazole and posaconazole 
are recommended for prophylaxis and treatment of both invasive and chronic 
fungal infections such as aspergillosis and aspergilloma. Emergence of 
azole-resistant among A. fumigatus isolates have been reported in other 
countries including Tanzania ascribed to either previous antifungal 
treatment, prophylaxis or triazoles use in agriculture. The use of azole based 
fungicides in the robust horticulture in Kenya is a significant risk factor for 
antifungal resistance. The study proposes to analyze environmental isolates 
of Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger for the 
presence of resistance against the triazoles antifungals. Fungicide naïve soils 
were obtained from uncultivated virgin fields while fungicide experience 
soils were collected from flower, agricultural and horticultural fields and 
greenhouses within Naivasha sub-county and Nairobi County. The fungal 
isolates were subjected to antifungal susceptibility to triazoles using broth 
micro dilution method. A total of 492 samples were analyzed in Nairobi, 52 
isolates were identified and they resistance were as follow: A. fumigatus 
(32%), A. niger (26.09%), A. flavus (33.33%) and A .terreus (0%) and in 
Naivasha 44 isolates were isolated out of which 25 were A. fumigatus and its 
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resistance was at 36%.  Data were analyses using student T test and showed 
they no different between resistant and susceptible isolates from the two 
location. Data generated will serve to inform on the current status of triazoles 
resistance pattern and to raise concern emerging antifungal resistance in 
clinical practice.  




 Aspergillus species are found worldwide, it has isolated in organic 
matter, soil and decaying organic matter, Most of the Aspergillus species 
sporulated highly (Balajee, 2009, Mann et al., 2003). The conidia hence is 
carried by wind and inhaled causing infection in individual whose immune 
system is compromised (Perfect et al., 2001). Azoles namely posaconazole, 
Voriconazole and intraconazole are drugs used as first line in treatment of 
aspergillosis (Walsh et al., 2008). Other drugs with sensitive against 
Aspergillus species are Anidulafungin, micafungin, caspofungin and 
amphotericin B.  Aspergillus fumigatus which causes most of the chronic and 
invasive aspergillosis (Denning et al., 2003, Walsh et al., 2008) is normally 
sensitive to the three classes of antigungal. However the recent past cases of 
patient with aspergillosis caused by A. fumigatus resistant to azoles has been 
reported (33). Aspergillus terreus is resistant to amphotericin B while 
Aspergillus pseudofischeri and A. lentulus is resistant to azoles intrinsically 
(Alcazar et al., 2008).   
 Azole resistance in Aspergillus infection due to azole treatment 
failure is an emerging health problem (Van der Linden et al., 2013. Van der 
Linden et al., 2011, Vermeulen et al., 2013). Surveillance reports have 
showed geographical spread of azole resistant species in clinical and 
environment in Africa, Europe, Asia, North and South America and Middle 
East (Vermeulen et al., 2013, Chowdhary et al., 2014). In contrast 
Netherland surveillance studies showed that azole resistance is endemic, 
TR46/Y121F/T289A and TR34/L98H cyp51A gene mediated resistance 
been the most common (Van der Linden et al., 2011).Multicenter 
international surveillance network study reported 3.2% triazoles resistance. 
Majority of resistant isolates were Aspergillus species at 78% and 22% of the 
other sibling species (A. lentulus, A. udagawae and A. thermomutatus) 
(Lamoth, 2016, Van der Linden et al., 2015). 
 The common reported mechanism of azoles resistance is alteration of 
the azoles drugs target i.e. lanosterol 14-α-demethylase and mutation in gene 
cyp51A (Chen et al., 2005, Mellado et al., 2005, Mellado et al., 2004, Diaz-
Guerra et al., 2003, Mann et al., 2003). Substitution usually occurs in codon 




98 by usually by substitution of histidine with leucine usually in the 
promoter region i.e. TR34/L98H.  Some authors have attribute widespread 
uses of azoles in agricultural may have led to selection of strain carrying the 
resistant gene (Snelders et al., 2012, Verweiji et al., 2009).  The use of azole 
based fungicides in the robust horticulture in Kenya is a significant risk 
factor for antifungal resistance. Recently several authors have reported a 
novel CYP51A mediated resistance with high resistance level to 
Voriconazole, TR46/Y121F/T289A  also has be isolated from clinical 
sources and environmental in Europe, Africa, Latin America and Indian 
(Verweij et al., 2015,Abdolrasouli et al., 2016, Le Pape et al., 2016, Fuhren 
et al., 2015). The aims of this study were to investigate the diversity and 
prevalence of azoles resistant Aspergillus species in Nairobi County and 
Naivasha sub-County. 
 
Materials and methods 
c. Sampling for environmental isolates 
Approximately 5g dry top surface soils from agricultural site were collected 
into a sterile 15 ml Falcon tube using a sterile plastic spoon. Soil samples 
were transported in a leak proof packaging in a cool box to KEMRI-Center 
for Microbiology Research for mycological investigations. 
d.  
e. Fungal culture and identification 
 Approximately a gram of the soil sample were suspended and 
vortexed thoroughly in 5 ml (0.5% w/v) saponin. The debris allowed to settle 
and the supernatant transferred to a fresh tube. The resulting suspension were 
then centrifuged, and the pellet suspended in a final volume of 500 μl sterile 
NaCl.  Hundred μicrolitres of the suspension were plated on Sabouraud 
dextrose agar containing; (a) no drug, (b) 1 μg/ml Itraconazole (c) 1 μg/ml 
Voriconazole.  All the Plates were incubated 30oC for 72 hours, checking 
daily for any growth. Colonies growing after incubation on triazoles free 
media were used as control and to access fungal diversity, while triazoles 
containing agar were used to determine resistant isolates.  
 
Triazoles susceptibility testing 
 Minimum inhibitory concentrations to Itraconazole (ITZ), 
Voriconazole (VCZ) and Posaconazole (PSZ) were tested by broth micro 
dilution according to the EUCAST reference method (EUCAST, 2008) with 
minor modification.  
 Exactly 9.6mg of azoles (Itraconazole, Voriconazole, posaconazole) 
powder were weighed and dissolved in 3.0ml of DMSO to get 1600µg/ml 
stock. Ten sterile tubes were used for serial dilution in each tube 3mls of 
DMSO were added. Starting with the first tube 3mls of the stock solution 
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were added, mix and 3mls form the mixed of the first tube was transfer to 
second tube mixed and pipette 3mls from the second and transfer to the third 
tubes and the process were continued up to the ten tubes. The second serial 
dilution were done using ten tubes, in each of the tubes (From first serial 
dilution tubes) 4.9ml of RPMI were added to each of the ten tubes 
 From each tubes of the second dilution 200µl were dispensed to 
microtitre plates and inoculated with 10µl of the inoculums. Plates were then 
incubated at 30°C for 72 h. The MIC values of all drugs were determined 
visually as the lowest concentrations with no visible growth. EUCAST drug 
susceptible controls strains DSM819 and ATCC46645 were used while azole 
resistant control isolates allele TR/L98H) and (allele G54W, ITZR + 
PSZR86) will be used. 
 
Results 
 A total of 492 of both Naïve and experience soils (246 Naïve soils 
and 246 experienced soils) were analyzed. At total 52 isolates were isolated 
from experience soil in Nairobi out which proportions of azoles resistance 
were as follows: A. fumigatus (32%), A. niger (26.09%), A. flavus (33.33%) 
and A .terreus (0%) as showed in table I. In Naivasha a total of 44 isolates 
were isolated, out of which 25 A. fumigatus were isolated and 36% were 
azole resistant as showed in Table 1.  
Table 1:  Showing isolates from experience soils both in Nairobi and Naivasha 




Susceptible Resistant’s Total 
no. 
Susceptible Resistant’s 
Fumigatus 25 17 (68.0%) 8 (32.0%) 25 14 (56.0%) 9 (36.0%) 
Niger 23 17(73.91%) 6(26.09%) 13 10(76.92%) 3(23.08%) 
flavus 3 2(66.67%) 1(33.33%) 3 2(66.67%) 1(33.33%) 
terreus 1 1(100%) 0 (0.0%) 3 3 (100%) 0(0.0%) 
Total 52 37 15 44 29 13 
 
 Out of 246 naïve soils analyzed In Nairobi a total of 40 isolates were 
isolated, of which resistance  were as follows:  A. fumigatus (19.23%), A 
niger (23.08%), A. flavus (0%), and A. terreus (0%) as showed in table 2. In 
Naivasha 50 Aspergillus species were isolated of which resistance were as 
follows:  A. fumigatus (19.05%), A niger (15.38%), A. flavus (0%), and A. 
terreus (0%) as showed in the table 2 below. 
Table 2: Showing isolates from Naïve soils both in Nairobi and Naivasha 
Nairobi Naïve soils isolates Naivasha Naïve soils Isolates 
Isolates Total 
no. 
Susceptible Resistant’s Total 
no. 
Susceptible Resistant’s 
fumigatus 26 21(80.77%) 5(19.23%) 21 17(80.95%) 4(19.05%) 
niger 13 10(76.92%) 3(23.08%) 26 22(84.62%) 4(15.38%) 




flavus 0 0(0.0%) 0(0.0%) 3 3 (100%) 0(0.0%) 
terreus 1 1 (100%) 0(0.0%) 0(0.0%) 0(0.0%) 0 (0.0%) 
Total 40 32(80.0%) 8(20.0%) 50 42(84.0%) 8(16.0%) 
 
T-test comparison of the resistant samples of Nairobi Naïve soils isolates 
to the Nairobi Experience soils isolates 
 The data was first normalized by getting the percentage resistance of 
the fungi. These were therefore used in testing for the variations. Using two-
sample t-test, there was no significant difference in percentage resistant 
isolates in Nairobi naïve samples (mean 6.2%) to the percentage resistance 
isolates in Nairobi experience isolates (mean 7.8%),  (T = 1.24, P = 0.271). 
 
Two-Sample T-Test and CI: Nairobi Naive, Nairobi experience 
 Two-sample T for Nairobi Naive soils vs Nairobi experience soils 
 
                     N      Mean     StDev   SE Mean 
Nairobi Naive        4      10.6      12.3       6.2 
Nairobi experience   4      22.9      15.6       7.8 
 
Difference = mu N. Naive - mu N. experience 
Estimate for difference:  -12.28 
95% CI for difference: (-37.78, 13.23) 
T-Test of difference = 0 (vs not =): T-Value = -1.24 P-Value = 0.271 DF = 5 
 
T-test comparison of the resistant samples of Nairobi Naïve soils isolates 
to the Naivasha naïve soil isolates 
 The result showed that there was no significant difference in 
percentage resistant isolates in Nairobi naïve samples (mean 6.2%) to the 
percentage resistant isolates in Naivasha naive isolates (mean 5.0%), (T = 
0.25, P = 0.814). 
Two-Sample T-Test and CI: Nairobi Naive, Naivasha naive 
Two-sample T for Nairobi Naive soils vs Naivasha naïve soils 
 
                 N      Mean     StDev   SE Mean 
Nairobi Naive    4      10.6      12.3       6.2 
Naivasha Naïve   4       8.6      10.1       5.0 
 
Difference = mu N. Naive - mu Naivasha naive 
Estimate for difference:  1.97 
95% CI for difference: (-18.46, 22.40) 
T-Test of difference = 0 (vs not =): T-Value = 0.25 P-Value = 0.814 DF = 5 
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T-test comparison of the resistant samples of Naivasha Naïve soil 
isolates to the Naivasha experience soil isolates 
 The result showed that there was no significant difference in 
percentage resistant isolates in Naivasha naïve samples (mean 5.0%) to the 
percentage resistant isolates in Naivasha experience isolates (mean 8.2%),  
(T = 1.51, P = 0.206). 
Two-Sample T-Test and CI: Naivasha experience, Naivasha naive 
Two-sample T for Naivasha experience vs Naivasha naive 
 
                      N      Mean     StDev   SE Mean 
Naivasha experience   4      23.1      16.4       8.2 
Naivasha naive        4       8.6      10.1       5.0 
 
Difference = mu Naivasha experience - mu Naivasha naive 
Estimate for difference:  14.50 
95% CI for difference: (-12.18, 41.17) 
T-Test of difference = 0 (vs not =): T-Value = 1.51 P-Value = 0.206 DF = 4 
 
T-test comparison of the resistant samples of Naivasha Naïve soil 
isolates to the Nairobi experience soil isolates 
 The result showed that there was no significant difference in 
percentage resistant isolates in Naivasha naïve samples (mean 5.0%) to the 
percentage resistant isolates in Nairobi experience isolates (mean 7.8%),  (T 
= 1.54, P = 0.185). 
Two-Sample T-Test and CI: Nairobi experience, Naivasha naive 
 
Two-sample T for N. experience vs Naivasha naive 
 
                     N      Mean     St Dev   SE Mean 
Nairobi experience   4      22.9      15.6       7.8 
Naivasha Naïve       4       8.6      10.1       5.0 
 
Difference = mu Nairobi experience - mu Naivasha naive 
Estimate for difference:  14.25 
95% CI for difference: (-9.56, 38.06) 
T-Test of difference = 0 (vs not =): T-Value = 1.54 P-Value = 0.185 DF = 5 
 
Discussion 
 We report the detection of environmental azole resistance Aspergillus 
species from both Naïve and experience soil in Nairobi County and Naivasha 
sub-County, Kenya. In experience soils, there were high percentages in 
resistance from Naivasha isolates this may be due to irrational used of 




fungicides in large scale horticultural farming as compare to Nairobi which 
was mostly small-scale farming  
 In the recent decades, there has an increase in opportunities infection 
one of them is aspergillosis (Walsh et al., 2008). Invasive fungal infection 
diseases are associated by high mortality and morbidity, partially because of 
failure to diagnosis early resulting in delay treatment. Most of the cross 
resistance in Aspergillus species by several authors have be reported 
infrequently, which mean they are infrequent to date. Low prevalence is due 
to variation in laboratory testing between different laboratories. 
 The detection of azole resistance of Aspergillus species was done 
based on medium containing azoles and micro dilution susceptibility testing. 
The uses of azole containing in screening environmental samples for the 
presence of resistance were first described using Itraconazole at a 
concentration of 4mg/liter (Snelders et al., 2009). Since then breakpoint have 
been proposed to be 1mg/liter for Itraconazole (Pfaller et al., 2009, Verweji 
et al., 2009). Which raises question that resistance isolates may go 
undetected. However it has been reported by several authors the MIC of 
most isolates against Itraconazole is 8mg/liter or more (Howard et al., 
2009,). In the study we further included Voriconazole (1mg/liter) and 
posaconazole (1mg/liter) SDA agar.  Student T test showed that they were no 
significant difference in percentage resistance (P= 0.271) of isolates from 
Nairobi naïve and experience soils isolates as well as in Naivasha from naïve 
and experience soils (P= 0.206). 
 The used of azole containing agar, hypothetically may results in 
laboratory generation of resistance in the recover isolates though expose. 
However it is believe that since de novo short azole exposure (Almost 72hr 
exposure) is for short time it may not cause resistance and detection of 
cyp51A alterations which cause necessary (Mellado et al., 2007). Acquire 
azole resistance usually develops due to response of fungi to azole exposure 
in patients or in agricultural (Chen et al., 2005, Howard et al., 2006, Verweij 
et al., 2009). Drug expose over a long periods and high numbers of 
reproducing fungi are some of the factors that played a role in the selection 
of resistance (Anderson, 2005). This condition is met in soil when 
agricultural azole applied remained in soils over a year and in patients with 
Cavitary Aspergillus (Hof, 2001). 
 Demethylation inhibitors and Azoles fungicides are recommend for 
used in plant protection (Hof, 2001). In Netherlands the used for fungicides 
in agricultural has double since mid1990s (Verweji et al., 2009). Similar 
trends has been observed in Denmark.  Resistant Aspergillus fumigatus is 
selected by used of azole fungicides or it can be introduced via importation 
of commercial compost to the environment, are one of the key factors in 
development of resistance (Verweji et al., 2009). In our study most of the 
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sites with resistant Aspergillus were previously exposed to azoles fungicides 
before. This is always hard to management aspergillosis because most 
laboratories do not perform sensitivity test and due to negative cultures. 
Hence the prevalence of azoles resistant Aspergillus species may be 
underestimated with risk of inappropriate therapy. We believe in our study 
and emerging reports on azole related resistance, we suggest that 
susceptibility testing for Aspergillus species should be performed routinely. 
 
Conclusion 
 The study found out that they are triazoles resistance Aspergillus 
species in the two county. High resistance in Naivasha sub county soils show 
that resistance could be catalyst by application of fungicides in agriculture. 
This posed a serious health public concern and more surveillance should 
done in the country.  
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